Racial differences in use of biologics for crohn's disease in a medicaid population

Introduction Immunomodulator (IMM) and biologic (anti-TNF) use in African Americans (AA) with Crohn's disease (CD) has been reported to be lower than in white patients (W); few data exist for Hispanic patients (H). We assessed racial differences in initiation of anti-TNF agents for patients wit...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gut 2011-04, Vol.60 (Suppl 1), p.A138-A138
Hauptverfasser:	Flasar, M, Mulani, P M, Yang, M, Chao, J, Lu, M, Cross, R
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics biologic therapy Crohn's disease Demography Diagnosis Medicaid Patients race Racial differences Steroid hormones Stockholders Surgery Tumor necrosis factor Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!